# Diazoxide in the Treatment of Type 1 Glycogenosis

> **NCT07739394** · — · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 15 (estimated)

## Conditions studied

- Glycogen Storage Disease Type I

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07739394
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-10-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07739394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07739394, "Diazoxide in the Treatment of Type 1 Glycogenosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07739394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*